Insider Transactions in Q3 2024 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 10
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|
|
Jul 09
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,600
-29.49%
|
$1,155,600
$321.16 P/Share
|
|
Jul 09
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|
|
Jul 08
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,600
-37.82%
|
$1,137,600
$316.35 P/Share
|
|
Jul 08
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|
|
Jul 05
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,600
-62.54%
|
$1,126,800
$313.55 P/Share
|
|
Jul 05
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|
|
Jul 03
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,600
-30.34%
|
$1,130,400
$314.14 P/Share
|
|
Jul 03
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|
|
Jul 02
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,600
-41.82%
|
$1,144,800
$318.06 P/Share
|
|
Jul 02
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|
|
Jul 01
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,600
-33.71%
|
$1,155,600
$321.01 P/Share
|
|
Jul 01
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+49.11%
|
$464,400
$129.49 P/Share
|